immunization

Overview

Immunization is the process by which an individual is made resistant to an infectious disease, most commonly through vaccination. In medical practice, the term is often used broadly to include both active immunization—the induction of an adaptive immune response by exposure to an antigen—and, in some contexts, passive immunization, in which preformed antibodies are administered for immediate but temporary protection. Immunization is a cornerstone of preventive medicine and public health because it reduces the incidence of vaccine-preventable diseases, severe complications, hospitalization, and death.

Biologically, immunization works by exposing the immune system to an antigen in a controlled way so that immune memory is established without causing the full disease. This memory can involve neutralizing antibodies, T-cell responses, or both. The recent literature summarized here emphasizes that protection is not determined by antibody titers alone; cellular immunity, vaccine delivery systems, formulation stability, and population-level uptake all contribute to the effectiveness of immunization programs. The entity is therefore relevant not only as a clinical intervention but also as a policy, manufacturing, and implementation target.

Focus of Latest Publications

Recent publications on immunization have focused on both vaccine effectiveness and the practical challenges of delivering vaccines across populations and settings. One mathematical modeling study used an ODE-based compartmental framework with a separate disease progression path for vaccinated individuals to compare different vaccine benefits, including blocking infections, decreasing transmission, expediting recovery, reducing severe morbidity, and preventing mortality. The model suggested that vaccines that reduce spread or accelerate recovery have a greater impact on overall population-level infection burden than vaccines that mainly reduce severe disease or death, which were found to have more limited effects on epidemic dynamics at the population level.

Several studies addressed implementation and evaluation issues in vaccination programs. A methodological paper on seasonal vaccines outlined key considerations for assessing the feasibility of network meta-analysis, emphasizing comparability across vaccine platform, formulation, dose, and valence, as well as the effects of seasonality, strain evolution, placebo or unvaccinated controls, prior vaccination or infection history, baseline risk, antigenic match, and time-varying epidemiology. The authors argued that these factors are important for preserving transitivity and homogeneity in comparative analyses and for supporting public health decision-making.

Other publications examined barriers to improving vaccine coverage and delivery. In Lubumbashi, expert perspectives on the SCAVA / VACCIN+CONNECT- OS initiative supported launching a local determinants study to identify household-level barriers to childhood immunization, with most respondents favoring socio-anthropological and communication-centered approaches alongside an actionable plan to address vaccine hesitancy and other constraints. A qualitative study in 11 US children's hospitals explored determinants of inpatient vaccine delivery, reflecting concern that many hospitalized children miss recommended vaccines. Another study surveyed adults and healthcare professionals across Mexico to describe knowledge, attitudes, and practices related to adult vaccination and vaccine-preventable diseases, aiming to identify gaps associated with low adult vaccine coverage.

A policy-related publication reported that a judge temporarily blocked HHS changes to vaccine recommendations, restoring the original vaccination schedule.

Key Publications

• NEWJul Mathematical Modeling Shows that Overall Infection Burden is Reduced More by Vaccines that Decrease Spread or Accelerate Recovery than those that Lower Severe Infections or Death. (Bulletin of mathematical biology, 2026, PMID 42400854): "Specifically, vaccine benefits that reduce disease spread or accelerate recovery have a more substantial impact on the overall population (both vaccinated and unvaccinated individuals) than do vaccine benefits that reduce severe infections or death."
• NEWJun Considerations for assessing the feasibility of network meta-analysis of seasonal vaccines. (Journal of comparative effectiveness research, 2026, PMID 42370650): "The concepts highlighted in this paper address important gaps in the feasibility assessment process for NMAs of seasonal vaccines, which are crucial for informing public health decisions and guiding vaccine policy and implementation."
• NEWJun Judge Blocks HHS Changes to Vaccine Recommendations. (The American journal of nursing, 2026, PMID 42343172): "Ruling temporarily restores original vaccination schedule."
• NEWJun Optimizing childhood vaccination coverage in Lubumbashi: Expert perspectives on the SCAVA / VACCIN+CONNECT- OS initiative. (Human vaccines & immunotherapeutics, 2026, PMID 42334467): "They specified multiple reasons and causes of vaccine hesitancy at the household level."
• NEWJul Barriers and Facilitators of Inpatient Vaccine Delivery at US Children's Hospitals: A Qualitative Study. (Pediatrics, 2026, PMID 42336386): "Despite many hospitalized children missing recommended vaccines, vaccines are rarely administered during hospitalization."
• May Knowledge, attitudes, and practices related to adult vaccination among adults and healthcare professionals across Mexico. (PloS one, 2026, PMID 42166462): "Despite substantial evidence supporting the benefits of vaccination across all age groups, achieving high vaccine coverage in adults remains a global challenge."